Transdermal delivery of estrogen therapy available by prescription "seems not to alter" the risk of venous thromboembolism (VTE), or blood clotting, in postmenopausal patients when compared to oral delivery, a new study suggests. The study was conducted by researchers at NYU Langone Medical Center and was published in the latest issue of Menopause: The Journal of the North American Menopause Society.
Full article >>
Thursday, March 26, 2009
New study suggests Rx estrogen delivery through the skin may show safety benefits as opposed to oral delivery
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment